Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooks D Cash

Showing results (21-30 of 241) with videos related to

Pageof 25
Sort By:
Annals of Internal Medicine|February 5, 2024
In primary care, second-line IBS therapy with amitriptyline vs. placebo reduced symptoms at 6 moTanvi Gupta, Brooks D Cash
Gastroenterology & Hepatology|April 3, 2018
Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease PatientsBenjamin Niland, Brooks D Cash
Therapeutic Advances in Gastroenterology|September 22, 2017
The place of eluxadoline in the management of irritable bowel syndrome with diarrheaSherry Levio, Brooks D Cash
Gastrointestinal Endoscopy|February 25, 2015
ResponseJoo Ha Hwang, Brooks D Cash
Gastrointestinal Endoscopy|July 19, 2014
ResponseShabana F Pasha, Brooks D Cash
The American Journal of Gastroenterology|December 18, 2015
Defining the Risk of Small Polyps: Potential Value of CTCBrooks D Cash, Perry J Pickhardt
Gastrointestinal Endoscopy|May 20, 2015
ResponseMouen A Khashab, Brooks D Cash
Gastroenterology Clinics of North America|February 22, 2011
The role of diagnostic testing in irritable bowel syndromeDavid L Furman, Brooks D Cash
Gastroenterology & Hepatology|March 23, 2017
Systematic Review: FDA-Approved Prescription Medications for Adults With ConstipationBrooks D Cash, Brian E Lacy
Expert Opinion on Investigational Drugs|March 11, 2005
Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoeaWilliam D Chey, Brooks D Cash
Pageof 25

Showing results (21-30 of 241) with videos related to

Sort By:
Pageof 25
Annals of Internal Medicine|February 5, 2024
In primary care, second-line IBS therapy with amitriptyline vs. placebo reduced symptoms at 6 moTanvi Gupta, Brooks D Cash
Gastroenterology & Hepatology|April 3, 2018
Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease PatientsBenjamin Niland, Brooks D Cash
Therapeutic Advances in Gastroenterology|September 22, 2017
The place of eluxadoline in the management of irritable bowel syndrome with diarrheaSherry Levio, Brooks D Cash
Gastrointestinal Endoscopy|February 25, 2015
ResponseJoo Ha Hwang, Brooks D Cash
Gastrointestinal Endoscopy|July 19, 2014
ResponseShabana F Pasha, Brooks D Cash
The American Journal of Gastroenterology|December 18, 2015
Defining the Risk of Small Polyps: Potential Value of CTCBrooks D Cash, Perry J Pickhardt
Gastrointestinal Endoscopy|May 20, 2015
ResponseMouen A Khashab, Brooks D Cash
Gastroenterology Clinics of North America|February 22, 2011
The role of diagnostic testing in irritable bowel syndromeDavid L Furman, Brooks D Cash
Gastroenterology & Hepatology|March 23, 2017
Systematic Review: FDA-Approved Prescription Medications for Adults With ConstipationBrooks D Cash, Brian E Lacy
Expert Opinion on Investigational Drugs|March 11, 2005
Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoeaWilliam D Chey, Brooks D Cash
Pageof 25